Alixia
Targeting the Tumor Ecosystem to address cancer drug resistance.
San Francisco, US
BiotechTherapeuticsDrug discoveryOncologyBiotechnology
Our compounds disrupt the metabolic and
inflammatory triggers in both cancer and quasi-cancerous
cells in the tumor microenvironment. By impacting multiple cell
types, we are enabling effective, lasting cancer treatments.
Meet the team2
The people behind Alixia
Olof Mollstedt
Founder
Helen Chen
Founder